Exportar registro bibliográfico


Metrics:

Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation (2018)

  • Authors:
  • Autor USP: SOARES, FERNANDO AUGUSTO - FO
  • Unidade: FO
  • DOI: 10.1007/s00428-018-2420-3
  • Subjects: NEOPLASIAS RENAIS; LEIOMIOMA; CARCINOMA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso à fonteDOI
    Informações sobre o DOI: 10.1007/s00428-018-2420-3 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CUNHA, Isabela Werneck da; COSTA, Walter Henriques da; MORINI, Mariana A; et al. Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation. Virchows Archiv: the european journal of pathology, Heidelberg, Springer, 2018. Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/30171332 > DOI: 10.1007/s00428-018-2420-3.
    • APA

      Cunha, I. W. da, Costa, W. H. da, Morini, M. A., Bezerra, S. M., Carraro, D. M., Torrezan, G. T., et al. (2018). Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation. Virchows Archiv: the european journal of pathology. doi:10.1007/s00428-018-2420-3
    • NLM

      Cunha IW da, Costa WH da, Morini MA, Bezerra SM, Carraro DM, Torrezan GT, Formiga MN da C, Guimarães GC, Zequi S de C, Soares FA. Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation [Internet]. Virchows Archiv: the european journal of pathology. 2018 ;Available from: https://www.ncbi.nlm.nih.gov/pubmed/30171332
    • Vancouver

      Cunha IW da, Costa WH da, Morini MA, Bezerra SM, Carraro DM, Torrezan GT, Formiga MN da C, Guimarães GC, Zequi S de C, Soares FA. Expanding morphological and clinical aspects of hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a case report in a patient with unusual morphology and clinical presentation [Internet]. Virchows Archiv: the european journal of pathology. 2018 ;Available from: https://www.ncbi.nlm.nih.gov/pubmed/30171332

    Referências citadas na obra
    King SC, Pollack LA, Li J et al (2014 Jun) Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010. J Urol 191(6):1665–1670
    Shuch B, Vourganti S, Ricketts CJ, Middleton L, Peterson J, Merino MJ, Metwalli AR, Srinivasan R, Linehan WM (2014 Feb 10) Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol 32(5):431–437
    Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP et al (2010) Molecular diagnosis and therapy of kidney cancer. Annu Rev Med 61:329–343
    Sanz-Ortega J, Vocke C, Stratton P, Linehan WM, Merino MJ (2013 Jan) Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Am J Surg Pathol 37(1):74–80
    Moch H, Cubilla AL, Humphrey PA et al (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs—part a: renal, penile, and testicular tumours. Eur Urol 70:93–105
    Merino MJ, Torres-Cabala C, Pinto P et al (2007) The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 31:1578–1585
    Wei MH, Toure O, Glenn GM et al (2006) Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43:18–27
    Smith SC, Trpkov K, Chen YB, Epstein JI et al (2016) Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma. Am J Surg Pathol 40(11):1457–1472
    Reed WB, Walker R, Horowitz R (1973) Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol 53:409–416
    Launonen V, Vierimaa O, Kiuru M, Isola J, Roth S, Pukkala E, Sistonen P, Herva R, Aaltonen LA (2001) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A 98:3387–3392
    Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I et al (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406–410
    Toro JR, Nickerson ML, Wei MH et al (2003) Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73:95–106
    Trpkov K, Hes O, Agaimy A et al (2016) Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome. Am J Surg Pathol 40:865–875
    Bardella C, El-Bahrawy M, Frizzell N et al (2011) Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status. J Pathol 225:4–11
    Tolvanen J, Uimari O, Ryynänen M et al (2012) Strong family history of uterine leiomyomatosis warrants fumarate hydratase mutation screening. Hum Reprod 27(6):1865–1869

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2020